BOSTON--(BUSINESS WIRE)--Eastern Bankshares, Inc. Announces Third Quarter 2025 Earnings Release Date, Conference Call and Webcast.

JP Morgan analysts see an “attractive setup” for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares, believing the company's Dupixent and Eylea drugs and cash on hand alone support valuation at current levels. In a note to clients on Friday, the analysts wrote that they expect several catalysts for the company over the next three to six months, including Phase 3 trial results for LAG3 melanoma treatment as well as several potential Eylea updates.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Public Service Enterprise Group, Genpact, The Progressive, Exelon and Butterfly Network.

Ondas (ONDS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

I reiterate my buy rating on The Trade Desk despite recent volatility and growth deceleration, seeing the selloff as a buying opportunity. TTD maintains a strong balance sheet with $1.7 billion in cash, no debt, solid GAAP profitability, and attractive profit margins. While growth is slowing due to tariffs and economic uncertainty, I expect sustainable double-digit top-line growth and reasonable long-term valuation.

The latest race in the technology sector has centered on developing the proper artificial intelligence (AI) infrastructure needed to handle a new generation of data-intensive applications. This creates a classic “picks and shovels” opportunity for investors who are willing to broaden their views on an industry.

MU's NAND sales climb 18% to $8.5 billion in FY25, with G9 SSDs and AI-driven storage fueling momentum into 2026.

ICEBlock, a widely used app, was dropped from the company's App Store after concerns were raised by the Justice Department that it could put law-enforcement officers at risk.

ICEBlock was dropped from the company's App Store after concerns were raised by the Justice Department that it could put law-enforcement officers at risk.

Alibaba (BABA) has more than doubled its stock price so far in 2025, getting more bullish optimism Friday with an upgrade from Erste. Diane King Hall talks about Alibaba's big run higher and how the Street is shaping their opinion on China tech.

THS rallies on operational efficiency, supply-chain savings and Harris Tea acquisition, despite volume declines and commodity pressures.

Cleveland-Cliffs (CLF) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks.com users have recently been watching Morgan Stanley (MS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks.com users have recently been watching Emcor Group (EME) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Recently, Zacks.com users have been paying close attention to Paypal (PYPL). This makes it worthwhile to examine what the stock has in store.

Rigetti Computing (RGTI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Recently, Zacks.com users have been paying close attention to Booking Holdings (BKNG). This makes it worthwhile to examine what the stock has in store.

Zacks.com users have recently been watching Apple (AAPL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Arbor Realty Trust (ABR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Medical Properties (MPW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.